Skip to main content
. 2022 Feb 8;79(13):1086–1095. doi: 10.1093/ajhp/zxac045

Table 1.

Office of the National Coordinator List of High-Priority Drug-Drug Interactions

Drug A Drug B
1. Amphetamine & Derivatives MAOIs
2. Atazanavir PPIs
3. Febuxostat Azathioprine & Mercaptopurine
4. SSRIs MAOIs
5. Irinotecan Strong CYP3A4 Inhibitors
6. Narcotic Analgesics MAOIsa
7. Tricyclic Antidepressants MAOIs
8. High-risk QT Prolonging Agents High-risk QT Prolonging Agents
9. Ramelteon Strong CYP1A2 Inhibitors
10. Strong CYP3A4 Inducers Protease Inhibitors
11. HMG Co-A Reductase Inhibitors CYP3A4 & Protease Inhibitors
12. CYP3A4 & Protease Inhibitors Ergot Alkaloids & Derivatives
13. Tizanidine CYP1A2 Inhibitors
14. Tranylcypromine Procarbazine
15. Triptans MAOIs

Abbreviations: MAOI, monoamine oxidase inhibitor; SSRI, selective serotonin reuptake inhibitor; CYP3A4, cytochrome P450 isozyme 3A4; CYP1A2, cytochrome P450 isozyme 1A2; PPI, proton pump inhibitor.